Study may prompt rethink on schizophrenia drugs

LONDON (Reuters) - Schizophrenia patients given a cheap older drug are less likely to die prematurely than people on newer treatments, despite the older product's well-known adverse side effects, Finnish researchers said on Monday. Study may prompt rethink on schizophrenia drugs

The Press Association
Schizophrenia Drug Limits May Have Led to Deaths, Lancet Says Bloomberg
Medical experts clash over use of 'danger' schizophrenia drug Independent